 | MEI Pharma (NASDAQ:MEIP) Upgraded at Zacks Investment Research
marketbeat.com - January 13 at 2:04 AM |
 | Those who invested in MEI Pharma (NASDAQ:MEIP) five years ago are up 62%
finance.yahoo.com - January 15 at 4:29 PM |
 | Those who invested in MEI Pharma (NASDAQ:MEIP) five years ago are up 74%
nasdaq.com - January 7 at 8:35 AM |
| Do Options Traders Know Something About MEI Pharma (MEIP) Stock We Don't?
finance.yahoo.com - December 1 at 2:38 PM |
| MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Just Cut Their EPS Forecasts Substantially
finance.yahoo.com - December 1 at 2:38 PM |
| MEI Pharma: There’s More Upside Ahead, Says Analyst Who Made a Winning Call
finance.yahoo.com - December 1 at 2:38 PM |
 | MEI Pharma, Kyowa Kirin Reveal Data From Zandelisib Trial In Follicular Lymphoma
markets.businessinsider.com - November 30 at 2:00 PM |
 | MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular ...
businesswire.com - November 30 at 9:00 AM |
| MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular Lymphoma
finance.yahoo.com - November 30 at 9:00 AM |
| MEI Pharma to Host Webcast on November 30, 2021 at 8:00 a.m. ET Reporting Data from Ongoing Global Phase 2 TIDAL Study of Zandelisib in Patients with Follicular Lymphoma
finance.yahoo.com - November 29 at 5:16 PM |
|
| One MEI Pharma, Inc. (NASDAQ:MEIP) insider reduced their stake by 40% in the previous year
nasdaq.com - November 24 at 8:45 AM |
| MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors
finance.yahoo.com - November 23 at 8:51 AM |
| MEI Pharma Reports First Quarter Fiscal Year 2022 Results and Operational Highlights
finance.yahoo.com - November 10 at 8:36 PM |
| MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - November 10 at 8:36 PM |
| MEI Pharma and Kyowa Kirin receive Orphan Drug Designation for Zandelisib for the Treatment of Follicular Lymphoma
finance.yahoo.com - November 10 at 10:34 AM |
| MEI Pharma Announces Acceptance of Three Abstracts for Presentation at the 63rd Annual American Society of Hematology Annual Meeting
finance.yahoo.com - November 4 at 10:24 AM |
| MEI Pharma, Inc. (MEIP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - November 2 at 6:04 PM |
| MEI Pharma, Inc. (NASDAQ:MEIP) Is Expected To Breakeven In The Near Future
finance.yahoo.com - October 22 at 1:54 PM |
| MEI Pharma to Present at the 2021 Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 22 at 9:56 AM |
| Companies Like MEI Pharma (NASDAQ:MEIP) Are In A Position To Invest In Growth
finance.yahoo.com - September 7 at 5:21 PM |
| MEI Pharma Reports Fiscal Year 2021 Results and Operational Highlights
finance.yahoo.com - September 2 at 9:01 PM |
| MEI Pharma, Inc. (MEIP) Reports Break-Even Earnings for Q4
finance.yahoo.com - September 2 at 9:01 PM |
| MEI Pharma to Present at Two Healthcare Conferences
finance.yahoo.com - September 2 at 9:23 AM |
| MEI Pharma to Release 2021 Fiscal Year End Financial Results and Provide Corporate Update on September 2, 2021
finance.yahoo.com - August 26 at 9:28 AM |
| Mei (MEIP) Begins Phase III Study for B-Cell Malignancies
finance.yahoo.com - August 18 at 4:12 PM |
| MEI Pharma and Kyowa Kirin Announce First Patient Dosed in the Phase 3 COASTAL Study Evaluating Zandelisib Plus Rituximab in Relapsed or Refractory Indolent Non Hodgkin's B-cell Lymphoma
finance.yahoo.com - August 17 at 5:47 PM |
| What Is The Ownership Structure Like For MEI Pharma, Inc. (NASDAQ:MEIP)?
nasdaq.com - August 10 at 12:50 PM |
| MEI Pharma Announces Planned Chief Financial Officer Transition
finance.yahoo.com - August 5 at 4:43 PM |
| MEI Pharma Inc (MEIP): Are Hedge Funds Right About This Stock?
finance.yahoo.com - July 29 at 8:30 PM |
| What You Need To Know About MEI Pharma, Inc.'s (NASDAQ:MEIP) Investor Composition
finance.yahoo.com - July 16 at 1:39 PM |
| MEI Pharma, Inc. Common Stock (MEIP)
nasdaq.com - July 15 at 7:26 PM |
| MEI Pharma Appoints Tina C. Beamon, J.D., as Chief Compliance Officer
finance.yahoo.com - July 15 at 9:24 AM |
| MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - July 1 at 6:01 PM |
|
| MEI Pharma and Kyowa Kirin to Present Clinical Data from Ongoing Studies Evaluating Zandelisib for Lymphoma at the 16th International Conference on Malignant Lymphoma Virtual Scientific Program
finance.yahoo.com - June 17 at 7:56 AM |
 | MEI Pharma, Kyowa Kirin Report First Patient Dosed In Phase 2 Study For Marginal Zone Lymphoma Candidate
benzinga.com - June 7 at 12:40 PM |
| MEI Pharma and Kyowa Kirin Announce First Patient with Marginal Zone Lymphoma Dosed in Expanded Global Phase 2 TIDAL Study Evaluating Zandelisib
finance.yahoo.com - June 7 at 12:40 PM |
| MEI Pharma to Host Investor and Analyst Video Webcast Event Following 2021 ASCO Annual Meeting
finance.yahoo.com - June 4 at 9:40 AM |
| MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2021
finance.yahoo.com - May 19 at 6:48 PM |
| MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - May 6 at 10:43 PM |
| MEI Pharma Reports Third Quarter Fiscal 2021 Results and Operational Highlights
finance.yahoo.com - May 6 at 5:37 PM |
| MEI Pharma Announces the Retirement of Chief Medical Officer Robert Mass and Promotion of Richard Ghalie to Chief Medical Officer
finance.yahoo.com - April 30 at 10:20 AM |
| Analysts Estimate MEI Pharma, Inc. (MEIP) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 29 at 7:02 PM |
| MEI Pharma and Kyowa Kirin Announce Completion of Patient Enrollment in Follicular Lymphoma Primary Efficacy Population of Global Phase 2 TIDAL Study Intended to Support Potential Accelerated Approval Application from U.S. Food and Drug Administration (FDA)
finance.yahoo.com - April 13 at 9:20 AM |
| MEI Pharma Presents Positive Preclinical Data For Cancer Drug Voruciclib
finance.yahoo.com - April 12 at 1:36 PM |
| MEI Pharma Reports Preclinical Data Demonstrating Ability of Voruciclib to Regulate MYC and Synergize with KRAS Inhibitors in KRAS Mutant Cancers
finance.yahoo.com - April 10 at 8:43 AM |
| MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 5 at 8:06 AM |
| MEIP Mar 2021 5.000 call
ca.finance.yahoo.com - March 17 at 3:07 PM |
| MEIP Jun 2021 7.500 call
ca.finance.yahoo.com - March 17 at 10:00 AM |
| MEI PHARMA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of MEI Pharma, Inc. - MEIP
finance.yahoo.com - March 13 at 2:55 AM |
 | MEI Pharma to Present Study at the American Association for Cancer Research (AACR) Annual Meeting 2021 Demonstrating that
bloomberg.com - March 12 at 11:51 AM |
| MEI Pharma to Present Study at the American Association for Cancer Research (AACR) Annual Meeting 2021 Demonstrating that Voruciclib Inhibits KRAS Mutant Cancers in Pre-Clinical Models
finance.yahoo.com - March 10 at 5:46 PM |
